Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress
Lists
Only you see this
Abstract
Low-dose Triple Pill BP lowering could improve long-term outcome from ICH.
BibTeX
@article{anderson2022triple,
author = {Craig S. Anderson and Anthony Rodgers and H Asita de Silva and Sheila Cristina Ouriques Martins and Catharina J.M. Klijn and Bimsara Senanayake and Ruth S. Freed and Laurent Billot and Hisatomi Arima and Nguyen Huy Thang and Wan Asyraf Wan Zaidi and Tinatin Kherkheulidze and Kolawole Wahab and Urs Fisher and Tsong‐Hai Lee and Christopher Chen and Octávio Marques Pontes‐Neto and Thompson Robinson and Ji‐Guang Wang and Sharon L. Naismith and Lili Song and Floris H.B.M. Schreuder and Richard I. Lindley and Mark Woodward and Stephen MacMahon and Rustam Al‐Shahi Salman and Clara K Chow and John Chalmers},
title = {{Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress}},
journal = {International Journal of Stroke},
year = {2022},
doi = {10.1177/17474930211068671},
}Loading related content...